S&P 500 Healthcare: 2 to Buy, 1 to Avoid
Update: 2025-10-08
Description
S&P 500 healthcare stocks: Which ones are healthy for your portfolio? Discover why medical device giant Becton Dickinson is losing its edge with sluggish growth and declining cash flow. Then, uncover two outperformers: Amgen, fueled by impressive revenue growth and strong cash flow, and Boston Scientific, riding a wave of double-digit revenue and earnings gains. Don't get stuck with the laggards – tune in to identify the healthcare stocks with real potential.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
